Meeting slides
Interactive presentation

Clinical Updates on the Management of Gout

Michael H. Pillinger, MD
Suggested Readings

The Emerging Role of Biotechnological Drugs in the Treatment of Gout.

Cavagna L, Taylor WJ. BioMed Res Int. 2014. doi: 10.1155/2014/264859. Epub 2014 Apr 16.

Imaging in gout: a review of the recent developments.

Chowalloor PV, et al. Ther Adv Musculoskelet Dis. 2014;6(4):131-143.

New medications in development for the treatment of hyperuricemia of gout.

Diaz-Torné C, et al. Curr Opin Rheumatol. 2015;27(2):164-169.

Pharmacodynamic, pharmacokinetic and tolerability evaluation of concomitant administration of lesinurad and febuxostat in gout patients with hyperuricaemia.

Fleischmann R, et al. Rheumatology. 2014;53(12):2167-2174.

The pathophysiology of hyperuricaemia and its possible relationship to cardiovascular disease, morbidity and mortality.

Gustafsson D, Unwin R. BMC Nephrology. 2013;14:164.

Emerging therapies for gout.

Edwards NL, So A. Rheum Dis Clin North Am. 2014;40(2):375-387.

The association of gout with socioeconomic status in primary care: a cross-sectional observational study.

Hayward RA, et al. Rheumatology (Oxford). 2013;52(11):2004-2008.

The crystallization of monosodium urate.

Martillo MA, et al. Curr Rheumatol Rep. 2014;16(2):400. doi:10.1007/s11926-013-0400-9.

Racial and gender disparities in patients with gout.

Singh JA. Curr Rheumatol Rep. 2013;15(2):307. doi:10.1007/s11926-012-0307-x.

Gout and its comorbidities: implications for therapy.

Stamp LK, Chapman PT. Rheumatology (Oxford). 2013;52(1):34-44.

Improved health-related quality of life and physical function in patients with refractory chronic gout following treatment with pegloticase: evidence from phase III randomized controlled trials.

Strand V, et al. J Rheumatol. 2012;39(7):1450-1457.

Recent advances in management of gout.

Suresh E, Das P. QJM. 2012;105(5):407-417.

Linked Resources

Clinical Tools

2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia.

Khanna D, et al. Arthritis Care Res (Hoboken). 2012;64(10):1431-1446.

2012 American College of Rheumatology guidelines for management of gout. Part 2: therapy and antiinflammatory prophylaxis of acute gouty arthritis.

Khanna D, et al. Arthritis Care Res (Hoboken). 2012;64(10):1447-1461.

Evolution of management of gout: a comparison of recent guidelines

Khanna PP, FitzGerald J. Curr Opin Rheumatol. 2015;27(2):139-146.

2015 Gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Neogi T, Jansen TL, Dalbeth N, et al. Ann Rheum Dis. 2015;74(10):1789-1798

Educational Materials for Patients and Their Families

What Is Gout? Fast Facts: An Easy-to-Read Series of Publications for the Public

A brochure in simplified language from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health


Patient brochure from the American Colllege of Rheumatology

Gout Education for Patients

Patient information from the Gout & Uric Acid Education Society

Related activities
1.00 CME/CE

Improving Outcomes for Patients With Gout

Updates on Diagnosis and Evidence-Based Management

Faculty: Michael Pillinger, MD; Paul Doghramji, MD; Lawrence Edwards, MD
Release: 01/14/2016
Expiration: 01/13/2017